学会発表 

Inatani M, Aibeta Crossover Study Group
Crossover randomized multicentre clinical trial comparing the efficacy and tolerability of fixed- combinations of 0.1% brimonidine/0.5% timolol versus 1% dorzolamide/0.5% timolol as adjunctive therapies to prostaglandin analogues: Aibeta Crossover Study
The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) New Orleans, Luisiana, USA, 2023 April 23-27.

Kunikane E, Orii Y, Inoue A, Inatani M.
Effect of patient factors on ocular pharmacokinetics in ophthalmic drug administration.
The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) New Orleans, Luisiana, USA, 2023 April 23-27.

Inatani M
Crossover trial comparing fixed-combinations of 0.1% brimonidine/timolol vs 1% dorzolamide/timolol as adjunctive therapies to prostaglandin analogues: Aibeta Crossover Study
10th World Glaucoma Congress Rome, Italy June 28-July 1 2023.

Takehiro Matsumura, Takefumi Yamaguchi, Yoshihiro Takamura , and Masaru Inatani
Changes in corneal higher-order aberrations during treatment for infectious keratitis
The 16th Joint Meeting of Korea-China-Japan Ophthalmologists, Seoul Korea, 2023 November24-26.